Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Intervalo de año de publicación
1.
Photochem Photobiol Sci ; 22(3): 487-501, 2023 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-36402936

RESUMEN

Harmaline (1) and harmalol (2) represent two 3,4-dihydro-ß-carboline (DHßCs) most frequently reported in a vast number of living systems. Fundamental aspects including the photosensitizing properties, cellular uptake, as well as the cyto- and phototoxicity of 1 and 2 were investigated herein. The molecular basis underlying the investigated processes are elucidated. Data reveal that both alkaloids show a distinctive pattern of extracellular DNA photodamage. Compound 1 induces a DNA photodamage profile dominated by oxidised purines and sites of base loss (AP sites), whereas 2 mostly induces single-strand breaks (SSBs) in addition to a small extent of purine oxidative damage. In both cases, DNA oxidative damage would occur through type I mechanism. In addition, a concerted hydrolytic attack is suggested as an extra mechanism accounting for the SSBs formation photoinduced by 2. Subcellular internalisation, cyto- and phototoxicity of 1 and 2 and the corresponding full-aromatic derivatives harmine (3) and harmol (4) also showed quite distinctive patterns in a structure-dependent manner. These results are discussed in the framework of the potential biological, biomedical and/or pharmacological roles reported for these alkaloids. The subtle structural difference (i.e., the exchange of a methoxy group for a hydroxyl substituent at C(7)) between harmaline and harmalol, gives rise to distinctive photosensitizing and subcellular localisation patterns.


Asunto(s)
Alcaloides , Harmalina , Harmalina/farmacología , Harmalina/química , Carbolinas/farmacología , Carbolinas/química , ADN
2.
Braz J Psychiatry ; 38(1): 65-72, 2016 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-27111702

RESUMEN

OBJECTIVE: To conduct a systematic literature review of animal and human studies reporting anxiolytic or antidepressive effects of ayahuasca or some of its isolated alkaloids (dimethyltryptamine, harmine, tetrahydroharmine, and harmaline). METHODS: Papers published until 3 April 2015 were retrieved from the PubMed, LILACS and SciELO databases following a comprehensive search strategy and using a predetermined set of criteria for article selection. RESULTS: Five hundred and fourteen studies were identified, of which 21 met the established criteria. Studies in animals have shown anxiolytic and antidepressive effects of ayahuasca, harmine, and harmaline, and experimental studies in humans and mental health assessments of experienced ayahuasca consumers also suggest that ayahuasca is associated with reductions in anxiety and depressive symptoms. A pilot study reported rapid antidepressive effects of a single ayahuasca dose in six patients with recurrent depression. CONCLUSION: Considering the need for new drugs that produce fewer adverse effects and are more effective in reducing anxiety and depression symptomatology, the described effects of ayahuasca and its alkaloids should be further investigated.


Asunto(s)
Ansiolíticos/farmacología , Antidepresivos/farmacología , Banisteriopsis , Animales , Ansiolíticos/uso terapéutico , Antidepresivos/uso terapéutico , Ansiedad/tratamiento farmacológico , Trastorno Depresivo/tratamiento farmacológico , Harmalina/farmacología , Harmina/farmacología , Humanos , Ratones , N,N-Dimetiltriptamina/farmacología , Ratas
3.
Braz. J. Psychiatry (São Paulo, 1999, Impr.) ; Braz. J. Psychiatry (São Paulo, 1999, Impr.);38(1): 65-72, Jan.-Mar. 2016. tab, graf
Artículo en Inglés | LILACS | ID: lil-776489

RESUMEN

Objective: To conduct a systematic literature review of animal and human studies reporting anxiolytic or antidepressive effects of ayahuasca or some of its isolated alkaloids (dimethyltryptamine, harmine, tetrahydroharmine, and harmaline). Methods: Papers published until 3 April 2015 were retrieved from the PubMed, LILACS and SciELO databases following a comprehensive search strategy and using a predetermined set of criteria for article selection. Results: Five hundred and fourteen studies were identified, of which 21 met the established criteria. Studies in animals have shown anxiolytic and antidepressive effects of ayahuasca, harmine, and harmaline, and experimental studies in humans and mental health assessments of experienced ayahuasca consumers also suggest that ayahuasca is associated with reductions in anxiety and depressive symptoms. A pilot study reported rapid antidepressive effects of a single ayahuasca dose in six patients with recurrent depression. Conclusion: Considering the need for new drugs that produce fewer adverse effects and are more effective in reducing anxiety and depression symptomatology, the described effects of ayahuasca and its alkaloids should be further investigated.


Asunto(s)
Humanos , Animales , Ratas , Ansiolíticos/farmacología , Banisteriopsis , Antidepresivos/farmacología , Ansiedad/tratamiento farmacológico , Ansiolíticos/uso terapéutico , N,N-Dimetiltriptamina/farmacología , Trastorno Depresivo/tratamiento farmacológico , Harmalina/farmacología , Harmina/farmacología , Ratones , Antidepresivos/uso terapéutico
4.
Bioorg Med Chem ; 16(14): 6689-95, 2008 Jul 15.
Artículo en Inglés | MEDLINE | ID: mdl-18558492

RESUMEN

Twenty-three heterocyclic compounds were evaluated for their potential as trypanothione reductase inhibitors. As a result, the harmaline, 10-thiaisoalloxazine, and aspidospermine frameworks were identified as the basis of inhibitors of Trypanosoma cruzi trypanothione reductase. Two new compounds showed moderately strong, linear competitive inhibition, namely N,N-dimethyl-N-[3-(7-methoxy-1-methyl-3,4-dihydro-9H-beta-carbolin-9-yl)propyl]amine (15) and 1,3-bis[3-(dimethylamino)propyl]-1,5-dihydro-2H-pyrimido[4,5-b][1,4]benzothiazine-2,4(3H)-dione (21), with K(i) values of 35.1+/-3.5microM and 26.9+/-1.9microM, respectively. Aspidospermine (25) inhibited T. cruzi TryR with a K(i) of 64.6+/-6.2microM. None of the compounds inhibited glutathione reductase. Their toxicity toward promastigotes of Leishmania amazonensis was assessed.


Asunto(s)
Inhibidores Enzimáticos/química , NADH NADPH Oxidorreductasas/antagonistas & inhibidores , Tripanocidas/química , Animales , Productos Biológicos , Flavinas/química , Flavinas/farmacología , Harmalina/química , Harmalina/farmacología , Alcaloides Indólicos/química , Alcaloides Indólicos/farmacología , Leishmania/efectos de los fármacos , Quinolinas/química , Quinolinas/farmacología , Trypanosoma cruzi/enzimología
5.
J Ethnopharmacol ; 112(3): 507-13, 2007 Jul 25.
Artículo en Inglés | MEDLINE | ID: mdl-17532158

RESUMEN

The use of the hallucinogenic brew ayahuasca, obtained from infusing the shredded stalk of the malpighiaceous plant Banisteriopsis caapi with the leaves of other plants such as Psychotria viridis, is growing in urban centers of Europe, South and North America in the last several decades. Despite this diffusion, little is known about its effects on emotional states. The present study investigated the effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in members of the Santo Daime, an ayahuasca-using religion. Standard questionnaires were used to evaluate state-anxiety (STAI-state), trait-anxiety (STAI-trait), panic-like (ASI-R) and hopelessness (BHS) in participants that ingested ayahuasca for at least 10 consecutive years. The study was done in the Santo Daime church, where the questionnaires were administered 1h after the ingestion of the brew, in a double-blind, placebo-controlled procedure. While under the acute effects of ayahuasca, participants scored lower on the scales for panic and hopelessness related states. Ayahuasca ingestion did not modify state- or trait-anxiety. The results are discussed in terms of the possible use of ayahuasca in alleviating signs of hopelessness and panic-like related symptoms.


Asunto(s)
Ansiedad/tratamiento farmacológico , Banisteriopsis/química , Trastorno Depresivo/tratamiento farmacológico , Pánico/efectos de los fármacos , Extractos Vegetales/farmacología , Adulto , Ansiedad/psicología , Bebidas , Brasil , Trastorno Depresivo/psicología , Método Doble Ciego , Femenino , Frutas/química , Harmalina/administración & dosificación , Harmalina/química , Harmalina/farmacología , Harmina/administración & dosificación , Harmina/análogos & derivados , Harmina/química , Harmina/farmacología , Humanos , Masculino , Persona de Mediana Edad , Estructura Molecular , N,N-Dimetiltriptamina/administración & dosificación , N,N-Dimetiltriptamina/química , N,N-Dimetiltriptamina/farmacología , Extractos Vegetales/administración & dosificación , Extractos Vegetales/química , Hojas de la Planta/química , Psicometría/métodos , Religión , Encuestas y Cuestionarios , Resultado del Tratamiento
6.
Life Sci ; 79(22): 2099-104, 2006 Oct 26.
Artículo en Inglés | MEDLINE | ID: mdl-16904699

RESUMEN

beta-carboline alkaloids are found in several medicinal plants and display a variety of actions on the central nervous, muscular and cardiovascular systems. The aim of the present study was to evaluate the effects of systemic administration of beta-carboline alkaloids on object recognition in mice. Adult Swiss mice received an intra-peritoneal injection (i.p.) of alkaloids (1.0, 2.5 or 5.0 mg/kg) 30 min before training in an object recognition task. The fully aromatic beta-carbolines, harmine and harmol, induced an enhancement of short-term memory (STM) at all doses tested when compared to controls. Harmaline, a dihydro beta-carboline and inverse agonist of the MK-801 binding site on the N-methyl-d-aspartate (NMDA) receptor, also induced an enhancement of both short-term memory (STM) and long-term memory (LTM). These results demonstrate that systemic administration of beta-carboline alkaloids can improve object recognition memory in mice.


Asunto(s)
Alcaloides/farmacología , Carbolinas/farmacología , Harmalina/farmacología , Harmina/farmacología , Reconocimiento en Psicología/fisiología , Alcaloides/administración & dosificación , Animales , Carbolinas/administración & dosificación , Harmalina/administración & dosificación , Harmina/administración & dosificación , Inyecciones Intraperitoneales , Masculino , Ratones , Modelos Animales , Reconocimiento en Psicología/efectos de los fármacos
7.
J Pharmacol Toxicol Methods ; 46(3): 137-43, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-12183189

RESUMEN

INTRODUCTION: Certain drugs can induce tremor in small animals and can be used as Parkinson's disease or essential experimental tremor models. However, the use of arbitrary scales for evaluating tremor in experimental models is limited by observer subjectivity. Progress in electronics and computer science has allowed a more precise quantification of tremor. The objective of the present study was to validate a newly developed low-cost method of spectral registration and analysis of tremor in free-moving rats. METHODS: Male Wistar rats, 3-4 months of age, previously placed for 5 min inside a sensor cage, were administered with different doses of eserine (0.25-1.5 mg/kg), oxotremorine (0.25-1.5 mg/kg) or harmaline (7.5-60 mg/kg). Drug-induced tremor was recorded during 10 min using a computerized system composed of force transducers, a signal conditioning circuit, a digitizing interface and a microcomputer. The signal transmitted to the computer was quantified, stored and analyzed for its amplitude and frequency by means of specific programs. RESULTS: Tremor was induced with an amplitude that was dose-dependent for all drugs used. Tremor frequency was dose-dependent for oxotremorine and eserine, but not for harmaline. The performance of the system was compared with that of other systems described in behavioral instrumentation literature. DISCUSSION: The present data indicate that the new system is capable of detecting the tremor induced by drugs, and that the programs used for spectral analysis allow the quantification of the amplitude and the frequency of the tremor in free-moving rats.


Asunto(s)
Procesamiento de Señales Asistido por Computador , Temblor/inducido químicamente , Animales , Relación Dosis-Respuesta a Droga , Harmalina/farmacología , Masculino , Oxotremorina/farmacología , Ratas , Ratas Wistar
8.
Acta Physiol Lat Am ; 31(3): 173-81, 1981.
Artículo en Inglés | MEDLINE | ID: mdl-7187588

RESUMEN

In isolated cat heart papillary muscle electrically driven, harmaline (HME) concentrations of 4.15 to 16.6 X 10(-5) M induced a dose dependent negative inotropic effect both at temperatures of 30 and 37 C. In fact, HME decreased both peak tension developed (PTD) and velocity of development of tension (dT/dt) and increased time to peak tension (TPT). The same concentrations induced also a dose-dependent increase of the effective refractory period (ERP). Concentrations of HME lower than 4.15 X 10(-5) M did not show any effect in papillary muscle. In isolated atria of the same cats either spontaneously beating or electrically driven, at 30 C, HME induced a dual inotropic effect. In fact, concentrations of 8.3 X 10(-5) M and 24.9 X 10(-5) M induced an increase in both PTD and dT/dt and lengthening of time to peak tension (TPT). Higher HME concentrations such as 41.5 X 10(-5) M induced a decrease in dT/dt, a negative inotropic effect, but still lengthened the TPT. In both preparations, whenever the dT/dt was depressed the PTD was diminished in spite of the prolongation of TPT. The lesser density of adrenergic innervation and catecholamines concentration in papillary muscle than in atrial myocardium probably explains the negative inotropic action of HME in ventricular myocardium as compared to the dual inotropic effect observed in atria.


Asunto(s)
Alcaloides/farmacología , Harmalina/farmacología , Atrios Cardíacos/efectos de los fármacos , Ventrículos Cardíacos/efectos de los fármacos , Animales , Gatos , Depresión Química , Relación Dosis-Respuesta a Droga , Contracción Miocárdica/efectos de los fármacos , Músculos Papilares/efectos de los fármacos , Temperatura
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA